Logo image of CLSD

CLEARSIDE BIOMEDICAL INC (CLSD) Stock Analyst Earnings Estimates

NASDAQ:CLSD - Nasdaq - US1850631045 - Common Stock - Currency: USD

0.4451  -0.05 (-10.48%)

After market: 0.431 -0.01 (-3.17%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CLSD revenue by date.CLSD revenue by date.
1.33M
-95.50%
8.226M
518.50%
1.664M
-79.77%
4.049M
143.33%
3.791M
-6.37%
14.819M
290.90%
67.019M
352.25%
145.91M
117.71%
254.54M
74.45%
259.92M
2.11%
335.36M
29.02%
EBITDA
YoY % growth
CLSD ebitda by date.CLSD ebitda by date.
-30.13M
-6,747.73%
-24.777M
17.77%
-28.656M
-15.66%
-33.61M
-17.29%
-83.032M
-147.05%
-66.906M
19.42%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
CLSD ebit by date.CLSD ebit by date.
-30.28M
-4,783.87%
-24.844M
17.95%
-28.882M
-16.25%
-27.961M
3.19%
-48.963M
-75.12%
-63.155M
-28.98%
-20.509M
67.53%
36.035M
275.70%
116.08M
222.13%
156.79M
35.07%
222.16M
41.69%
Operating Margin
CLSD operating margin by date.CLSD operating margin by date.
-2,276.69%-302.02%-1,735.70%-690.56%-1,291.57%-426.17%-30.60%24.70%45.60%60.32%66.25%
EPS
YoY % growth
CLSD eps by date.CLSD eps by date.
-0.55
-5,400.00%
-0.53
3.64%
-0.45
15.09%
-0.42
7.71%
-0.62
-49.97%
-0.51
18.11%
-0.16
69.50%
0.28
280.33%
0.90
219.09%
1.27
42.07%
1.63
27.80%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.10
-4.48%
-0.08
20.44%
-0.14
-38.42%
-0.20
-84.53%
-0.27
-157.74%
-0.30
-271.79%
-0.29
-112.22%
Revenue
Q2Q % growth
173.4K
92.67%
173.4K
-83.29%
654.259K
113.81%
102K
-95.62%
9.09M
5,142.21%
9.136M
5,168.74%
9.182M
1,303.42%
EBITDA
Q2Q % growth
-7.399M
1.58%
-2.937M
49.26%
-14.213M
-105.30%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-6.562M
13.54%
-6.104M
-2.87%
-9.257M
-29.49%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.11
26.67%
-0.110.000.67%
Q4 2024
Q2Q % growth
-0.10
-25.00%
-0.100.00-0.93%
Q3 2024
Q2Q % growth
-0.10
33.33%
-0.130.0321.12%
Q2 2024
Q2Q % growth
-0.10
33.33%
-0.140.0427.38%
Q1 2024
Q2Q % growth
-0.15 -0.14-0.01-6.87%
Q4 2023
Q2Q % growth
-0.08
50.00%
-0.090.0110.36%
Q3 2023
Q2Q % growth
-0.15
-15.38%
-0.160.015.12%
Q2 2023
Q2Q % growth
-0.15
-15.38%
-0.14-0.01-3.80%
Q1 2023
Q2Q % growth
-0.15
-15.38%
-0.14-0.01-5.04%
Q4 2022
Q2Q % growth
-0.16
-151.61%
-0.13-0.03-24.49%
Q3 2022
Q2Q % growth
-0.13
-62.50%
-0.03-0.10-274.86%
Q2 2022
Q2Q % growth
-0.13
-18.18%
-0.130.003.45%
Q1 2022
Q2Q % growth
-0.13 -0.08-0.05-55.43%
Q4 2021
Q2Q % growth
0.31
321.43%
0.160.1591.95%
Q3 2021
Q2Q % growth
-0.08
-60.00%
-0.090.017.73%
Q2 2021
Q2Q % growth
-0.11
15.38%
-0.130.0215.96%
Q1 2021
Q2Q % growth
-0.13
-85.71%
-0.10-0.03-30.05%
Q4 2020
Q2Q % growth
-0.14
-100.00%
-0.12-0.02-20.40%
Q3 2020
Q2Q % growth
-0.05
70.59%
-0.120.0757.98%
Q2 2020
Q2Q % growth
-0.13
40.91%
-0.12-0.01-7.49%
Q1 2020
Q2Q % growth
-0.07
84.44%
-0.120.0539.80%
Q4 2019
Q2Q % growth
-0.07 -0.070.006.41%
Q3 2019
Q2Q % growth
-0.17 -0.16-0.01-4.17%
Q2 2019
Q2Q % growth
-0.22 -0.400.1845.05%
Q1 2019
Q2Q % growth
-0.45 -0.41-0.04-9.61%
CLSD Yearly EPS VS EstimatesCLSD Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
2.33M
913.04%
173.4K2.157M1,243.71%
Q4 2024
Q2Q % growth
306K
-95.18%
180.203K125.797K69.81%
Q3 2024
Q2Q % growth
1.038M
20.84%
125.317K912.683K728.30%
Q2 2024
Q2Q % growth
90K
-91.16%
129.203K-39.203K-30.34%
Q1 2024
Q2Q % growth
230K
5,650.00%
596.7K-366.7K-61.45%
Q4 2023
Q2Q % growth
6.345M
1,822.73%
4.522M1.823M40.31%
Q3 2023
Q2Q % growth
859K
218.15%
163.373K695.627K425.79%
Q2 2023
Q2Q % growth
1.018M
167.89%
126.684K891.316K703.57%
Q1 2023
Q2Q % growth
4K
-98.86%
146.88K-142.88K-97.28%
Q4 2022
Q2Q % growth
330K
-98.72%
97.92K232.08K237.01%
Q3 2022
Q2Q % growth
270K
-91.21%
6.648M-6.378M-95.94%
Q2 2022
Q2Q % growth
380K
-51.28%
382.5K-2.5K-0.65%
Q1 2022
Q2Q % growth
350K
1,066.67%
2.933M-2.583M-88.07%
Q4 2021
Q2Q % growth
25.69M
256,800.00%
18.127M7.563M41.72%
Q3 2021
Q2Q % growth
3.07M
-10.50%
2.629M441K16.77%
Q2 2021
Q2Q % growth
780K
122.86%
589.733K190.267K32.26%
Q1 2021
Q2Q % growth
30K
-99.27%
2.165M-2.135M-98.61%
Q4 2020
Q2Q % growth
10K
-99.48%
1.316M-1.306M-99.24%
Q3 2020
Q2Q % growth
3.43M
2,350.00%
1.548M1.882M121.58%
Q2 2020
Q2Q % growth
350K
600.00%
1.359M-1.009M-74.25%
Q1 2020
Q2Q % growth
4.1M
8,100.00%
2.04M2.06M100.98%
Q4 2019
Q2Q % growth
1.94M 3.73M-1.79M-47.99%
Q3 2019
Q2Q % growth
140K 15.3K124.7K815.03%
Q2 2019
Q2Q % growth
50K 6.559K43.441K662.36%
CLSD Yearly Revenue VS EstimatesCLSD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS4.9% 6.88% 2.4% 5%
Revenue-1.92% 0% 51.59% 382.42%